Tricholumin A, a Highly Transformed Ergosterol Derivative from the

Org. Lett. , 2018, 20 (19), pp 6306–6309. DOI: 10.1021/acs.orglett.8b02821. Publication Date (Web): September 26, 2018. Copyright © 2018 American C...
0 downloads 0 Views 922KB Size
Letter Cite This: Org. Lett. 2018, 20, 6306−6309

pubs.acs.org/OrgLett

Tricholumin A, a Highly Transformed Ergosterol Derivative from the Alga-Endophytic Fungus Trichoderma asperellum Yin-Ping Song,†,‡ Zhen-Zhen Shi,† Feng-Ping Miao,† Sheng-Tao Fang,† Xiu-Li Yin,† and Nai-Yun Ji*,† †

Yantai Institute of Coastal Zone Research, Chinese Academy of Sciences, Yantai 264003, China University of Chinese Academy of Sciences, Beijing 100049, China



Org. Lett. 2018.20:6306-6309. Downloaded from pubs.acs.org by UNIV OF SUNDERLAND on 10/05/18. For personal use only.

S Supporting Information *

ABSTRACT: Tricholumin A (1) with an unprecedented carbon skeleton was isolated from the fungus Trichoderma asperellum cf44-2, an endophyte from the marine brown alga Sargassum sp. Its structure and relative configuration were identified by extensive 1D/2D NMR and mass spectrometric data, and the absolute configuration was assigned by X-ray diffraction and ECD calculations. Compound 1 represents a highly transformed ergosterol derivative, and it exhibited inhibition of some pathogenic microbes and marine phytoplankton species.

six methyls, seven methylenes, nine methines, and five nonprotonated carbons by DEPT experiments. In addition, another nonprotonated carbon resonating at δC 110.4 was revealed by the HMBC spectrum. The above NMR data partially resembled those of ergosterol.14 All proton signals were assigned to their respective carbons by interpretation of the HSQC data. COSY correlations (Figure 1) of H-15/H-16/H-17/H-18/H-19/H-15 indicated the presence of a cyclopentyl group (ring D), which was methylated at C-19 based on the COSY correlation between H-26 and H-19 and HMBC correlations from H-26 to C-15, C-18, and C-19. HMBC correlations from H-23 to C-21, C-22, and C-24, from H-24 to C-21, C-22, and C-23, and from H-25 to C-20, C-21, and C-22 suggested a dimethylbutyl side chain, attaching to ring D through C-18 by the COSY correlation between H-18 and H20. In addition, C-10 was also bonded to ring D via C-15 by the HMBC correlations from H-27 to C-10 and C-15, and it was then extended to two carbonyl groups (C-9 and C-13) by the COSY correlation between H-11 and H-12 and HMBC correlations from H-27 to C-9 and C-11 and from H-12 to C13. On the other hand, a vinyl group, flanked by the nonprotonated C-5 and C-8 in view of the HMBC correlations from H-6 to C-5 and from H-7 to C-8, was speculated by the COSY correlation between H-6 and H-7. Its attachment to C-14 and then C-13 was established by the HMBC correlations from H-28 to C-5, C-13, and C-14. The residual COSY correlations of H-1/H-2/H-3/H-4 together with HMBC correlations from H27 to C-1 and from H-4 to C-5 supported the connectivity of ring A. Furthermore, the dihydrofuranyl (ring C) and hemiketal groups were confirmed by comparison of NMR data with the literature,15 whereas C-3 and C-20 were hydroxylated on the basis of their deshielded NMR signals.14 To satisfy the unsaturation requirement, C-8 was found to attach to C-9.

N

atural steroids with various physiological functions are almost ubiquitous in plants, animals, and microbes of terrestrial and marine origin.1 They commonly feature a cyclopentano perhydrophenanthrene nucleus, and oxidation, substitution, and cyclization of this core and its affiliated methyls and side chains greatly diversify the structures.2−7 Filamentous fungi have proven to be prolific sources of ergosterol and its congeners. Except for the regular ergosteroids, a few derivatives with cleaved, contracted, and expanded ring systems have been discovered from them.8−11 These derivatives often possess high novelty and have attracted much attention for natural product research. Marine-derived fungi have contributed a number of new ergosterol analogues with great diversity and intriguing bioactivity,12,13 encouraging our further investigation toward them. As a result, one novel ergosterol derivative (1) with a unique carbon scaffold was isolated and identified from the marine alga-endophytic fungus Trichoderma asperellum cf44-2. Herein, the isolation, structure elucidation, and bioactivity as well as possible biogenetic pathway of this compound are described in detail. T. asperellum cf44-2 was isolated from the inner tissue of the brown alga Sargassum sp. collected from Zhoushan Islands. Its fermentation was performed statically at room temperature for 30 days, and then EtOAc extracts were purified by repeated column chromatography on silica gel and RP-18 and preparative TLC as well as semipreparative HPLC to yield compound 1, trivially named tricholumin A. Tricholumin A (1) was obtained as colorless crystals, and a molecular formula of C28H44O6 was determined by HREIMS (m/z 476.3135 [M]+, calcd for 476.3138), requiring seven degrees of unsaturation. In combination with HSQC data, the 1 H NMR spectrum (Table 1) displayed four methyl doublets, two methyl singlets, one double doublet, and one double doublet of double doublets ascribable to two oxymethines, two doublets attributable to two olefinic protons, and a range of signals at δH 1.3−3.1 for methylenes and methines. The 13C NMR spectrum (Table 1) exhibited 27 resonances, sorted into © 2018 American Chemical Society

Received: September 4, 2018 Published: September 26, 2018 6306

DOI: 10.1021/acs.orglett.8b02821 Org. Lett. 2018, 20, 6306−6309

Letter

Organic Letters Table 1. 1H and 13C NMR Data for 1 (in CDCl3) pos

δH (J in Hz)

δC, type

1a 1b 2a 2b 3 4 5 6 7 8 9 10 11a 11b 12a 12b 13 14 15 16a 16b 17a 17b 18 19 20 21 22 23 24 25 26 27 28

2.49, td (13.6, 3.8) 1.66, m 2.02, m 1.52, m 4.14, dddd (10.5, 10.5, 5.0, 5.0) 1.90, m

30.7, CH2

6.16, d (5.8) 6.02, d (5.9)

2.70, br t (13.0) 1.82, m 3.03, br d (12.8) 2.20, td (12.6, 4.3)

2.23, m 1.73, m 1.44, m 1.66, m 1.39, m 1.81, m 1.97, m 3.39, dd (7.1, 5.5) 1.50, m 2.07, m 0.82, d (6.3) 0.92, d (6.9) 0.80, d (6.6) 1.21, d (6.6) 1.06, s 1.18, s

29.9, CH2 67.3, CH 43.7, CH2 95.9, C 137.0, CH 129.5, CH 110.4, C 209.1, C 54.8, C 33.5, CH2

Figure 2. Two energy-minimized conformers with Boltzmann populations and NOE correlations of 1.

H-7 and H-27. Additionally, H-15, H-18, and C-26 were allowed to be on the same face of ring D based on the NOE correlations of H-26 with H-15 and H-18. However, the relative configurations between rings B and D and at C-20 and C-21 remained unable to be resolved on the basis of the NMR data. The flexible architecture of 1 prompted us to ascertain its absolute configuration through crystallography. Fortunately, a suitable single crystal was obtained in MeOH with a drop of water after repeated efforts and was subjected to the X-ray diffraction analysis using Cu Kα radiation. As a result, the absolute configuration of 1 was assigned to be 3S, 5S, 8R, 10R, 14S, 15R, 18S, 19S, 20R, and 21R (Figure 3). To further confirm

37.6, CH2 213.6, C 54.6, C 54.7, CH 29.0, CH2 30.9, CH2 50.7, CH 36.8, CH 79.3, CH 41.8, CH 26.6, CH 16.5, CH3 22.3, CH3 10.7, CH3 24.9, CH3 21.3, CH3 19.2, CH3

Figure 3. X-ray crystallographic structure of 1 (note: a different numbering system is used for the structure in the text).

the absolute configuration of 1, its electronic circular dichroism (ECD) spectrum was determined in MeOH, which exhibited a positive Cotton effect at 310 nm. Ring B with two carbonyl groups should be responsible for this peak, due to the lack of any chromophore in the other moieties. Regardless of rotations of the hydroxy and methyl groups as well as the side chain, two energy-minimized conformers (1A and 1B) (Figure 2) within a 3 kcal/mol energy threshold from the global minimum were obtained after conformational optimization at the B3LYP/631G(d) level in MeOH with the integral equation formalism variant of the polarizable continuum model via Gaussian 09 software,16 and then they were used to simulate the ECD spectrum at the same level through the time-dependent density function theory method. The Boltzmann-weighted ECD curve, depicted by SpecDis software with σ = 0.2,17 agreed well with the experimental one (Figure 4), which corroborated the absolute configuration of 1. Biosynthetically, compound 1 could be traced back to the ergosterol that was also obtained in the present study. A plausible biogenetic pathway was proposed, as shown in Scheme 1. Initiation by dehydrogenating ergosterol at C-14 and C-15 generates tetraenol 1a,10 followed by further deprotonation at C-9 to yield intermediate 1b. Its C-5 position is then attacked by OH− to form tetraendiol 1c, which undergoes oxidation by dioxygenases and monooxygenases to afford 1d.18 After the

Figure 1. Structure and key COSY and HMBC correlations of 1.

Thus, the planar structure of 1 was assigned as a highly transformed ergosterol derivative (Figure 1). The relative configuration of 1 was established in part by analysis of coupling constants and NOE correlations (Figure 2). H-1a and H-3 were oriented to be axial according to their respective constants. The double bond between C-6 and C-7 was assigned a Z geometry by their small coupling constants,15 and it was syn to C-28 and H-1b by the NOE correlations of H28 with H-1b and H-6. Furthermore, the cofacial property of C-7 and C-27 was verified by the obvious NOE correlation between 6307

DOI: 10.1021/acs.orglett.8b02821 Org. Lett. 2018, 20, 6306−6309

Letter

Organic Letters

V. splendidus, and Pseudoalteromonas citrea).19−21 The results show that 1 could inhibit the four phytoplankton species tested, with IC50 values of 0.56, 0.37, 0.59, and 0.27 μg/mL, respectively. It also exhibited weak antibacterial activity against V. harveyi, V. splendidus, and P. citrea with inhibitory zones of 10, 7.5, and 8.0 mm, respectively, at 50 μg/disk. On the other hand, its antifungal activity against Glomerella cingulata, a phytopathogen in agriculture, was also assayed, and the MIC value was determined to be 12 μg/mL.



ASSOCIATED CONTENT

S Supporting Information *

Figure 4. Experimental and calculated ECD spectra of 1.

The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acs.orglett.8b02821. Experimental section, Cartesian coordinates, 1D/2D NMR, HREIMS, IR, and UV spectra (PDF)

Scheme 1. Plausible Biogenetic Pathway of 1

Accession Codes

CCDC 1864431 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge via www.ccdc.cam.ac.uk/data_request/cif, or by emailing data_ [email protected], or by contacting The Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: +44 1223 336033.



AUTHOR INFORMATION

Corresponding Author

*E-mail: [email protected]. ORCID

Nai-Yun Ji: 0000-0002-6526-4731 Notes

The authors declare no competing financial interest.



ACKNOWLEDGMENTS Financial support from the National Natural Science Foundation of China (31670355), the Natural Science Foundation for Distinguished Young Scholars of Shandong Province (JQ201712), the Open Fund of Key Laboratory of Experimental Marine Biology, the CAS (KF2017NO4), the Youth Innovation Promotion Association of the CAS (2013138), and the SelfFund from Yantai Institute of Coastal Zone Research, the CAS (Y755031012) is gratefully acknowledged.



REFERENCES

(1) Salvador, J. A. R.; Carvalho, J. F. S.; Neves, M. A. C.; Silvestre, S. M.; Leitão, A. J.; Silva, M. M. C.; Sá e Melo, M. L. Nat. Prod. Rep. 2013, 30, 324−374. (2) Li, K.; Scott, A. M.; Brant, C. O.; Fissette, S. D.; Riedy, J. J.; Hoye, T. R.; Li, W. Org. Lett. 2017, 19, 4444−4447. (3) Fattorusso, E.; Taglialatela-Scafati, O.; Petrucci, F.; Bavestrello, G.; Calcinai, B.; Cerrano, C.; Di Meglio, P.; Ianaro, A. Org. Lett. 2004, 6, 1633−1635. (4) Kuo, P. C.; Kuo, T. H.; Damu, A. G.; Su, C. R.; Lee, E. J.; Wu, T. S.; Shu, R.; Chen, C. M.; Bastow, K. F.; Chen, T. H.; Lee, K. H. Org. Lett. 2006, 8, 2953−2956. (5) Zhang, G. W.; Ma, X. Q.; Kurihara, H.; Zhang, C. X.; Yao, X. S.; Su, J. Y.; Zeng, L. M. Org. Lett. 2005, 7, 991−994. (6) Machida, K.; Abe, T.; Arai, D.; Okamoto, M.; Shimizu, I.; de Voogd, N. J.; Fusetani, N.; Nakao, Y. Org. Lett. 2014, 16, 1539−1541. (7) Keyzers, R. A.; Daoust, J.; Davies-Coleman, M. T.; Soest, R. V.; Balgi, A.; Donohue, E.; Roberge, M.; Andersen, R. J. Org. Lett. 2008, 10, 2959−2962.

cleavage between C-8 and C-9 and intramolecular SN2 reaction accompanied by a series of electron and proton transfers, two carbonyl groups and one norbornyl group are created, as shown in 1e and 1f. Subsequent oxidation produces 1g, and further cyclization through an SN2 reaction and cleavage due to ring strain of the norbornyl moiety leads to the formation of 1 via 1h. The highlights of these transformations are the oxidative cleavage between C-8 and C-9 of ergosterol and construction of ring D in 1. To develop new inhibitors against harmful microalgae and pathogenic bacteria that greatly threaten marine aquaculture, compound 1 was evaluated for inhibition of four phytoplankton species (Chattonella marina, Heterosigma akashiwo, Karlodinium veneficum, and Prorocentrum donghaiense) and five aquatic pathogens (Vibrio anguillarum, V. harveyi, V. parahemolyticus, 6308

DOI: 10.1021/acs.orglett.8b02821 Org. Lett. 2018, 20, 6306−6309

Letter

Organic Letters (8) Ratnaweera, P. B.; Williams, D. E.; Patrick, B. O.; de Silva, E. D.; Andersen, R. J. Org. Lett. 2015, 17, 2074−2077. (9) Hu, Z.; Wu, Y.; Xie, S.; Sun, W.; Guo, Y.; Li, X. N.; Liu, J.; Li, H.; Wang, J.; Luo, Z.; Xue, Y.; Zhang, Y. Org. Lett. 2017, 19, 258−261. (10) Xue, J.; Wu, P.; Xu, L.; Wei, X. Org. Lett. 2014, 16, 1518−1521. (11) Cui, C. M.; Li, X. M.; Meng, L.; Li, C. S.; Huang, C. G.; Wang, B. G. J. Nat. Prod. 2010, 73, 1780−1784. (12) Rateb, M. E.; Ebel, R. Nat. Prod. Rep. 2011, 28, 290−344. (13) Ji, N. Y.; Wang, B. G. Fungal Divers 2016, 80, 301−342. (14) Kwon, H. C.; Zee, S. D.; Cho, S. Y.; Choi, S. U.; Lee, K. R. Arch. Pharmacal Res. 2002, 25, 851−855. (15) Chen, X. T.; Bhattacharya, S. K.; Zhou, B.; Gutteridge, C. E.; Pettus, T. R. R.; Danishefsky, S. J. J. Am. Chem. Soc. 1999, 121, 6563− 6579. (16) Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G. A.; Nakatsuji, H.; Caricato, M.; Li, X.; Hratchian, H. P.; Izmaylov, A. F.; Bloino, J.; Zheng, G.; Sonnenberg, J. L.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; Montgomery, J. A., Jr.; Peralta, J. E.; Ogliaro, F.; Bearpark, M.; Heyd, J. J.; Brothers, E.; Kudin, K. N.; Staroverov, V. N.; Keith, T.; Kobayashi, R.; Normand, J.; Raghavachari, K.; Rendell, A.; Burant, J. C.; Iyengar, S. S.; Tomasi, J.; Cossi, M.; Rega, N.; Millam, J. M.; Klene, M.; Knox, J. E.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Martin, R. L.; Morokuma, K.; Zakrzewski, V. G.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Dapprich, S.; Daniels, A. D.; Farkas, O.; Foresman, J. B.; Ortiz, J. V.; Cioslowski, J.; Fox, D. J. Gaussian 09, revision C.01; Gaussian, Inc.: Wallingford, CT, 2010. (17) Bruhn, T.; Hemberger, Y.; Schaumlöffel, A.; Bringmann, G. SpecDis, version 1.51; University of Wuerzburg, Germany, 2011. (18) Dewick, P. M. Medicinal Natural Products: A Biosynthetic Approach, 2nd ed.; John Wiley & Sons: New York, 2002; p 25. (19) Miao, F. P.; Liang, X. R.; Yin, X. L.; Wang, G.; Ji, N. Y. Org. Lett. 2012, 14, 3815−3817. (20) Pierce, C. G.; Uppuluri, P.; Tristan, A. R.; Wormley, F. L., Jr.; Mowat, E.; Ramage, G.; Lopez-Ribot, J. L. Nat. Protoc. 2008, 3, 1494− 1500. (21) Shi, Z. Z.; Miao, F. P.; Fang, S. T.; Yin, X. L.; Ji, N. Y. Phytochem. Lett. 2018, 27, 101−104.

6309

DOI: 10.1021/acs.orglett.8b02821 Org. Lett. 2018, 20, 6306−6309